[go: up one dir, main page]

TWI800922B - Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage - Google Patents

Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage Download PDF

Info

Publication number
TWI800922B
TWI800922B TW110134263A TW110134263A TWI800922B TW I800922 B TWI800922 B TW I800922B TW 110134263 A TW110134263 A TW 110134263A TW 110134263 A TW110134263 A TW 110134263A TW I800922 B TWI800922 B TW I800922B
Authority
TW
Taiwan
Prior art keywords
short peptide
preventing
treating diseases
diseases related
nerve damage
Prior art date
Application number
TW110134263A
Other languages
Chinese (zh)
Other versions
TW202311280A (en
Inventor
江文德
許芸綺
李洳龍
Original Assignee
東海大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 東海大學 filed Critical 東海大學
Priority to TW110134263A priority Critical patent/TWI800922B/en
Publication of TW202311280A publication Critical patent/TW202311280A/en
Application granted granted Critical
Publication of TWI800922B publication Critical patent/TWI800922B/en

Links

TW110134263A 2021-09-14 2021-09-14 Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage TWI800922B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW110134263A TWI800922B (en) 2021-09-14 2021-09-14 Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW110134263A TWI800922B (en) 2021-09-14 2021-09-14 Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage

Publications (2)

Publication Number Publication Date
TW202311280A TW202311280A (en) 2023-03-16
TWI800922B true TWI800922B (en) 2023-05-01

Family

ID=86690499

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110134263A TWI800922B (en) 2021-09-14 2021-09-14 Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage

Country Status (1)

Country Link
TW (1) TWI800922B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080305212A1 (en) * 2007-04-16 2008-12-11 Solae, Llc Protein Hydrolysate Compositions Having Improved Sensory Characteristics and Physical Properties
US20120087862A1 (en) * 2006-08-09 2012-04-12 Homestead Clinical Corporation Organ-specific proteins and methods of their use
US20170183386A1 (en) * 2015-07-16 2017-06-29 Nuritas Limited Peptides, and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120087862A1 (en) * 2006-08-09 2012-04-12 Homestead Clinical Corporation Organ-specific proteins and methods of their use
US20080305212A1 (en) * 2007-04-16 2008-12-11 Solae, Llc Protein Hydrolysate Compositions Having Improved Sensory Characteristics and Physical Properties
US20170183386A1 (en) * 2015-07-16 2017-06-29 Nuritas Limited Peptides, and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
專書 R.E. Aluko, Food protein-derived peptides: Production, isolation, and purification Proteins in Food Processing (Second Edition) Woodhead Publishing 2018;期刊 Chibuike C. Udenigwe and Rotimi E. Aluko, "Food Protein-Derived Bioactive Peptides: Production, Processing, and Potential Health Benefits" J Food Sci., Vol 77,No.1, Jan 2012, pages R11-24 *
期刊 Chibuike C. Udenigwe and Rotimi E. Aluko, "Food Protein-Derived Bioactive Peptides: Production, Processing, and Potential Health Benefits" J Food Sci., Vol 77,No.1, Jan 2012, pages R11-24

Also Published As

Publication number Publication date
TW202311280A (en) 2023-03-16

Similar Documents

Publication Publication Date Title
IL280483A (en) Muscle-directed cuffs and their use in the treatment of Pompe disease
IL280358B1 (en) Novel autotac chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprosing the same
PL3661954T3 (en) INTERLEUKIN 21 MUTEINS AND TREATMENT
MX376139B (en) KERATIN TREATMENT FORMULATIONS AND METHODS.
LT3586837T (en) COMPOSITIONS INCLUDING AMINO ACIDS FOR USE IN THE PREVENTION AND TREATMENT OF LIVER DISEASES
JOP20200033A1 (en) Amino acid compositions for the treatment of liver disease
MX2021013354A (en) Methods of treating and/or preventing actinic keratosis.
EP3290514C0 (en) USE OF PI4KIII ALPHA PROTEIN AND ASSOCIATED MEMBRANE PROTEIN COMPLEX IN THE TREATMENT OF ALZHEIMER'S DISEASE
EP3625245A4 (en) PEPTIDE COMPOUNDS, CONJUGATE COMPOUNDS AND THEIR USES IN THE TREATMENT OF INFLAMMATORY DISEASES
BR112019003816A2 (en) hair rinse treatment composition, method for treating chemically damaged hair and use of a composition
WO2017151860A8 (en) Human kynureninase enzyme variants having improved pharmacological properties
MX2020009532A (en) MODIFIED OLIGONUCLOTIDES FOR USE IN THE TREATMENT OF TAUOPATHIES.
IL285452A (en) A new recombinant diamine oxidase and its use in the treatment of diseases characterized by excess histamine
MX2021000542A (en) SOLUBILIZED APIRASES, METHODS AND USES.
KR102387136B9 (en) Peptide for preventing or treating hair loss and use thereof
UY38352A (en) INTEGRIN INHIBITORS ALFAVBETA6
CO6592047A2 (en) Topical ophthalmic peptide formulation
HUE059500T2 (en) Preparations containing amino acids for use in the treatment of obesity
WO2017189988A8 (en) Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage
IL304673A (en) Long-chain functional mono-di-carbohydrates and their derivatives, and their use for the prevention or treatment of diseases
EP3843690A4 (en) PERSONAL CARE SPRAY COMPOSITIONS AND METHODS WITH TRANS-1-CHLORINE-3,3,3-TRIFLUOROPROPEN
IL292689A (en) Topical preparations that include irak4 inhibitors for use in the treatment of skin conditions characterized by inflammation
TWI800922B (en) Short peptide, hydrolyzate containing the short peptide and its use for preventing or/and treating diseases related to nerve damage
IL286818A (en) Miricizumab for use in the treatment of Crohn's disease
EP3878454A4 (en) USE OF 3-O-SULFAMATE-16,16-DIMETHYL-D-HOMOEQUILENIN IN THE TREATMENT OF ONCOLOGICAL DISEASES